Sales & Marketing HSA growth and the opportunities emerging for investors and ... Paying attention to the intersection of public policy and business opportunity can be a winning strategy for start-ups and disrupters.
Partner Content Partner Content IATA's CEIV-Pharma Certification or HSA's GDP Certification? 13th Cold Chain Distribution Conference
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.